Vision
Lumenis Vision is renowned for technological breakthroughs ophthalmic lasers and a long list of industry gold standards. Our company pioneered the first argon laser photocoagulator for ophthalmology; the first approved marketer of Nd:YAG photodisruptor lasers; developed and introduced the breakthrough technology of multicolor photocoagulation along with the world’s first Laser Indirect Ophthalmoscope (LIO); developed and brought to market the revolutionary SLT technology for managing POAG, and more.
Today, Lumenis Vision offers you the confidence of doing business with a company that is truly committed to ophthalmology and to meeting your needs.
-
Lumenis Array LaserLink TM
VisionArray LaserLinkTM
Pattern Scanning Laser Technology
Lumenis introduces ArrayTM LaserLinkTM a technologically advanced delivery system that significantly enhances standard laser treatment by providing new pattern scanning capabilities to photocoagulation lasers and considerably reducing treatment time.  Array offers a range of laser spot sizes from 50µm to 1000µm in single spot mode, 100µm to 500µm in pattern scanning mode.
Examples of Scan Pattern Shapes
-
Lumenis DIGITALÂ TRIO
VisionDIGITALÂ TRIO
Taking Glaucoma and Retina treatments to the Next Level
The Digital Trio reimagines laser therapy with the first digital dual path SLT-YAG platform on the market. The Digital Trio configuration adds a state-of-the-art retinal care photocoagulator to the digital dual path SLT-YAG system. The platform is a comprehensive digital and imaging solution that streamlines practice efficiency and offers new ways to communicate with patients and peers.
Experience laser therapy reimagined with the Digital Duet and Digital Trio. -
Lumenis Novus Spectra®
VisionHigh-powered photocoagulator
Versatile | Portable | Powerful Â
The Lumenis Novus Spectra® is an innovative photocoagulator with an extensive set of features that deliver power and reliability with proprietary advancements in diode-pumped solid-state  technology.
-
Lumenis Optilight
Vision
A Bright Solution For Dry Eyes
Lumenis, the inventor of IPL, presents the first and only IPL FDA-approved for the management of dry eye disease due to MGD.
Introducing OptiLight – a bright solution for dry eyes. OptiLight elevates dry eye management with Lumenis’ patented Optimal Pulse Technology (OPT™) and user-centered design. Get the safe, precise, elegant procedure you want and the comfortable, effective therapy your patients need to manage dry eye disease with OptiLight. -
Lumenis Optima IPL
VisionOptima IPL
Treat the root cause: chronic inflammation
Optima IPL is a drug free, drop free light-based treatment, which targets the root causes – chronic inflammation.
Optima IPL treats periocular inflammatory conditions such as Rosacea and telangiectasia, which may lead to ocular surface conditions such as Dry Eye6,7. 80% of rosacea patients suffer from Meibomian Gland Dysfunction.
-
Lumenis Smart Selecta Trio
VisionSelective Laser Trabeculoplasty (SLT) for Glaucoma treatment
Laser Procedures for Glaucoma
Maximum flexibility; minimum footprint
The Lumenis Selecta® Trio™ represents the next generation of multi-modality products, offering retinal, cataract and advanced glaucoma therapies in a single platform. The unit’s integrated design, enhanced optics system and advanced laser cavity make the Trio one of the highest performing laser products in the market – maximum flexibility with minimum footprint.
-
Lumenis Smart532 Laser Photocoagulator
VisionSmart532 Laser Photocoagulator
Photocoagulation with SmartPulse Technology
Smart 532â„¢ is the newest photocoagulator by Lumenis,
enhanced with the advanced SmartPulseâ„¢ technology.
-
Lumenis Vision One – Retinopathy Laser
VisionMulti-Wavelength Photocoagulation System
Product Highlights
